Immune Responses to H5N1 Vaccine With and Without MF59 Adjuvant

Conditions:   Influenza;   HealthyInterventions:   Biological: H5N1 vaccine plus MF59 adjuvant;   Biological: H5N1 vaccine without adjuvantSponsors:   National Heart, Lung, and Blood Institute (NHLBI);   Center for Human Immunology, Autoimmunity and Inflammation;   National Institutes of Health Clinical Center (CC)Completed - verified December 2013
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials